Chapter 1. EVENT-DRIVEN PATIENT TRACKING SYSTEMS MARKET– Scope & Methodology

1.1. Market Segmentation

1.2. Assumptions

1.3. Research Methodology

1.4. Primary Sources

1.5. Secondary Sources

Chapter 2. EVENT-DRIVEN PATIENT TRACKING SYSTEMS MARKET– Executive Summary

2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)

2.2. Key Trends & Insights

2.3. COVID-19 Impact Analysis

      2.3.1. Impact during 2023 – 2030

      2.3.2. Impact on Supply – Demand

Chapter 3. EVENT-DRIVEN PATIENT TRACKING SYSTEMS MARKET– Competition Scenario

3.1. Market Share Analysis

3.2. Product Benchmarking

3.3. Competitive Strategy & Development Scenario

3.4. Competitive Pricing Analysis

3.5. Supplier - Distributor Analysis

Chapter 4. EVENT-DRIVEN PATIENT TRACKING SYSTEMS MARKET- Entry Scenario

4.1. Case Studies – Start-up/Thriving Companies

4.2. Regulatory Scenario - By Region

4.3 Customer Analysis

4.4. Porter's Five Force Model

       4.4.1. Bargaining Power of Suppliers

       4.4.2. Bargaining Powers of Customers

       4.4.3. Threat of New Entrants

       4.4.4. Rivalry among Existing Players

       4.4.5. Threat of Substitutes

Chapter 5. EVENT-DRIVEN PATIENT TRACKING SYSTEMS MARKET- Landscape

5.1. Value Chain Analysis – Key Stakeholders Impact Analysis

5.2. Market Drivers

5.3. Market Restraints/Challenges

5.4. Market Opportunities

Chapter 6. EVENT-DRIVEN PATIENT TRACKING SYSTEMS MARKET– By Type

6.1. Short Messaging Service (SMS)

6.2. Multimedia Messaging Service (MMS)

6.3. Interactive Voice Response(VIR)

6.4. Wireless Application Protocol(WAP)

Chapter 7. EVENT-DRIVEN PATIENT TRACKING SYSTEMS MARKET– By Application

7.1. Personal

7.2. Commercial

Chapter 8. EVENT-DRIVEN PATIENT TRACKING SYSTEMS MARKET– By Region

8.1. North America

8.2. Europe

8.3. The Asia Pacific

8.4. Latin America

8.5. Middle-East and Africa

Chapter 9. EVENT-DRIVEN PATIENT TRACKING SYSTEMS MARKET – Company Profiles – (Overview, Product Portfolio, Financials, Developments)

9.1. Company 1

9.2. Company 2

9.3. Company 3

9.4. Company 4

9.5. Company 5

9.6. Company 6

9.7. Company 7

9.8. Company 8

9.9. Company 9

9.10. Company 10